Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joke Bilcke

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
BMJ Global Health|August 24, 2025
How well do disease-specific studies and WHO-CHOICE cost estimates align? Example of estimating cost per episode of diarrhoea and respiratory syncytial virus in 128 low-income and middle-income countriesXiao Li, Joke Bilcke, Ernest O Asare, et al.
Human Vaccines & Immunotherapeutics|February 9, 2018
Economic evaluation of pneumococcal vaccines for adults aged over 50 years in BelgiumLander Willem, Adriaan Blommaert, Germaine Hanquet, et al.
Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Cost per episode of diarrhea and respiratory syncytial virus (RSV) in 128 low- and middle-income countries: how well do disease-specific and WHO-CHOICE estimates align?Xiao Li, Joke Bilcke, Ernest O Asare, et al.
Vaccine|September 18, 2010
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe"Mark Jit, Marie-Josée J Mangen, Hugues Melliez, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 28, 2015
Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and WalesJoke Bilcke, Ruth Chapman, Christina Atchison, et al.
Vaccine|September 1, 2009
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in EuropeMark Jit, Joke Bilcke, Marie-Josée J Mangen, et al.
Acta Cardiologica|December 31, 2015
Environmental triggers of acute myocardial infarction: results of a nationwide multiple-factorial population studyMarc J Claeys, Sarah Coenen, Charlotte Colpaert, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2022
Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like IllnessRobin Bruyndonckx, Joke Bilcke, Alike W van der Velden, et al.
The Journal of Infectious Diseases|August 12, 2022
Economic Burden and Health-Related Quality of Life of Respiratory Syncytial Virus and Influenza Infection in European Community-Dwelling Older AdultsZhuxin Mao, Xiao Li, Koos Korsten, et al.
NPJ Vaccines|January 19, 2026
Cost-effectiveness of maternal vaccine and/or monoclonal antibody strategies against respiratory syncytial virus in Belgian infantsXiao Li, Lander Willem, Dominique Roberfroid, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
BMJ Global Health|August 24, 2025
How well do disease-specific studies and WHO-CHOICE cost estimates align? Example of estimating cost per episode of diarrhoea and respiratory syncytial virus in 128 low-income and middle-income countriesXiao Li, Joke Bilcke, Ernest O Asare, et al.
Human Vaccines & Immunotherapeutics|February 9, 2018
Economic evaluation of pneumococcal vaccines for adults aged over 50 years in BelgiumLander Willem, Adriaan Blommaert, Germaine Hanquet, et al.
Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Cost per episode of diarrhea and respiratory syncytial virus (RSV) in 128 low- and middle-income countries: how well do disease-specific and WHO-CHOICE estimates align?Xiao Li, Joke Bilcke, Ernest O Asare, et al.
Vaccine|September 18, 2010
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe"Mark Jit, Marie-Josée J Mangen, Hugues Melliez, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 28, 2015
Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and WalesJoke Bilcke, Ruth Chapman, Christina Atchison, et al.
Vaccine|September 1, 2009
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in EuropeMark Jit, Joke Bilcke, Marie-Josée J Mangen, et al.
Acta Cardiologica|December 31, 2015
Environmental triggers of acute myocardial infarction: results of a nationwide multiple-factorial population studyMarc J Claeys, Sarah Coenen, Charlotte Colpaert, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2022
Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like IllnessRobin Bruyndonckx, Joke Bilcke, Alike W van der Velden, et al.
The Journal of Infectious Diseases|August 12, 2022
Economic Burden and Health-Related Quality of Life of Respiratory Syncytial Virus and Influenza Infection in European Community-Dwelling Older AdultsZhuxin Mao, Xiao Li, Koos Korsten, et al.
NPJ Vaccines|January 19, 2026
Cost-effectiveness of maternal vaccine and/or monoclonal antibody strategies against respiratory syncytial virus in Belgian infantsXiao Li, Lander Willem, Dominique Roberfroid, et al.
Pageof 6